000			01933 a2200541 4500
005			20250517022127.0
264		0	_c20160107
008			201601s 0 0 eng d
022			_a1873-3476
024	7		_a10.1016/j.ijpharm.2015.02.050 _2doi
040			_aNLM _beng _cNLM
100	1		_aSingh, Harinder
245	0	0	_aNano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety. _h[electronic resource]
260			_bInternational journal of pharmaceutics _cMay 2015
300			_a138-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antitubercular _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aBiological Availability
650	0	4	_aCalorimetry, Differential Scanning
650	0	4	_aChemical and Drug Induced Liver Injury _xetiology
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aCrystallography, X-Ray
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Carriers
650	0	4	_aEmulsions
650	0	4	_aLethal Dose 50
650	0	4	_aLipids _xchemistry
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMicroscopy, Atomic Force
650	0	4	_aMicroscopy, Electron, Transmission
650	0	4	_aNanomedicine
650	0	4	_aNanoparticles
650	0	4	_aParticle Size
650	0	4	_aPowder Diffraction
650	0	4	_aRats, Wistar
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aSolubility
650	0	4	_aTechnology, Pharmaceutical _xmethods
700	1		_aJindal, Sahil
700	1		_aSingh, Mandeep
700	1		_aSharma, Gaurav
700	1		_aKaur, Indu Pal
773	0		_tInternational journal of pharmaceutics _gvol. 485 _gno. 1-2 _gp. 138-51
856	4	0	_uhttps://doi.org/10.1016/j.ijpharm.2015.02.050 _zAvailable from publisher's website
999			_c24706129 _d24706129